14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 11, 2024 Buy 32 000 Pepose Jay Common Stock
Apr 11, 2024 Buy 48 000 Pepose Jay Stock Option (right to buy)
Mar 21, 2024 Buy 2 000 Schachle Joseph K Common Stock
Mar 21, 2024 Buy 10 000 Jhaveri Nirav S. Common Stock
Mar 18, 2024 Buy 25 000 Magrath George Common Stock
Feb 12, 2024 Buy 210 000 Jhaveri Nirav S. Employee Stock Option (right to buy)
Feb 12, 2024 Buy 140 000 Jhaveri Nirav S. Common Stock
Feb 12, 2024 Buy 225 000 Jayagopal Ashwath Employee Stock Option (right to buy)
Feb 12, 2024 Buy 75 000 Jayagopal Ashwath Common Stock
Feb 12, 2024 Buy 0 Jhaveri Nirav S.
Feb 12, 2024 Buy 0 Jayagopal Ashwath
Jan 18, 2024 Buy 20 000 Hoffmann Bernhard Common Stock
Jan 18, 2024 Buy 30 000 Hoffmann Bernhard Employee Stock Option (right to buy)
Jan 18, 2024 Buy 40 000 Zaremba Rabourn Amy Common Stock
Jan 18, 2024 Buy 60 000 Zaremba Rabourn Amy Employee Stock Option (right to buy)
Jan 10, 2024 Sell 3 950 Zaremba Rabourn Amy Common Stock
Jan 10, 2024 Sell 1 282 Patel Ronil A. Common Stock
Jan 10, 2024 Sell 4 031 Hoffmann Bernhard Common Stock
Jan 01, 2024 Buy 14 964 Pepose Jay Common Stock
Jan 01, 2024 Buy 22 090 Manuso James S J Common Stock
Jan 01, 2024 Buy 24 762 Rodgers Richard J Common Stock
Jan 01, 2024 Buy 19 418 Benton Susan Common Stock
Dec 01, 2023 Buy 49 692 Patel Ronil A. Common Stock
Dec 01, 2023 Buy 74 538 Patel Ronil A. Employee Stock Option (right to buy)
Nov 27, 2023 Buy 300 000 Schachle Joseph K Employee Stock Option (right to buy)
Nov 27, 2023 Buy 0 Schachle Joseph K
Nov 01, 2023 Buy 35 000 Pepose Jay Common Stock
Nov 01, 2023 Buy 35 000 Rodgers Richard J Common Stock
Nov 01, 2023 Buy 600 000 Magrath George Employee Stock Option (right to buy)
Nov 01, 2023 Buy 400 000 Magrath George Common Stock
Nov 01, 2023 Buy 0 Magrath George
Jun 06, 2023 Buy 10 976 Ainsworth Sean Common Stock
Jun 06, 2023 Buy 9 639 Ainsworth Sean Stock Option
Jun 06, 2023 Buy 10 976 Manuso James S J Common Stock
Jun 06, 2023 Buy 9 639 Manuso James S J Stock Option
Jun 06, 2023 Buy 10 976 Pepose Jay Common Stock
Jun 06, 2023 Buy 9 639 Pepose Jay Stock Option
Jun 06, 2023 Buy 10 976 Benton Susan Common Stock
Jun 06, 2023 Buy 9 639 Benton Susan Stock Option
Jun 06, 2023 Buy 10 976 Gallagher Cam Common Stock
Jun 06, 2023 Buy 9 639 Gallagher Cam Stock Option
Apr 24, 2023 Buy 20 000 Patel Ronil A. Common Stock
Apr 24, 2023 Buy 30 000 Patel Ronil A. Employee Stock Option (right to buy)
Apr 24, 2023 Buy 0 Patel Ronil A. Common Stock
Apr 24, 2023 Buy 18 000 Patel Ronil A. Employee Stock Option (right to buy)
Apr 24, 2023 Buy 20 000 Patel Ronil A. Employee Stock Option (right to buy)
Apr 24, 2023 Buy 18 800 Patel Ronil A. Employee Stock Option (right to buy)
Apr 24, 2023 Buy 15 000 Patel Ronil A. Employee Stock Option (right to buy)
Apr 24, 2023 Buy 25 956 Patel Ronil A. Employee Stock Option (right to buy)
Apr 19, 2023 Buy 2 819 Manuso James S J Common Stock
Apr 19, 2023 Buy 1 053 Benton Susan Common Stock
Apr 19, 2023 Buy 50 000 Rodgers Richard J Common Stock
Apr 19, 2023 Buy 468 Pepose Jay Common Stock
Jan 11, 2023 Buy 18 544 Manuso James S J Common Stock
Jan 11, 2023 Buy 13 013 Pepose Jay Common Stock
Jan 11, 2023 Buy 20 822 Rodgers Richard J Common Stock
Jan 11, 2023 Buy 16 267 Benton Susan Common Stock
Jan 10, 2023 Buy 134 456 Sooch Mina Common Stock
Jan 10, 2023 Buy 201 683 Sooch Mina Employee Stock Option (right to buy)
Jan 10, 2023 Buy 33 291 Pepose Jay Stock Option (right to buy)
Jan 10, 2023 Buy 46 608 Hoffmann Bernhard Common Stock
Jan 10, 2023 Buy 69 912 Hoffmann Bernhard Employee Stock Option (right to buy)
Jan 10, 2023 Buy 69 912 Zaremba Rabourn Amy Employee Stock Option (right to buy)
Jan 10, 2023 Buy 46 608 Zaremba Rabourn Amy Common Stock
Jan 04, 2023 Buy 1 574 Gallagher Cam Common Stock
Jan 04, 2023 Sell 1 574 Gallagher Cam Series B Warrant (right to buy)
Dec 31, 2022 Buy 0 Sooch Mina
Dec 31, 2022 Buy 0 Ainsworth Sean
Oct 19, 2022 Buy 1 574 Ainsworth Sean Common Stock
Oct 19, 2022 Sell 1 574 Ainsworth Sean Series B Warrant (right to buy)
Oct 11, 2022 Buy 787 Manuso James S J Common Stock
Oct 11, 2022 Sell 787 Manuso James S J Series B Warrant (right to buy)
Oct 03, 2022 Buy 3 148 Rodgers Richard J Common Stock
Oct 03, 2022 Sell 3 148 Rodgers Richard J Series B Warrant (right to buy)
Sep 06, 2022 Sell 1 023 Sooch Mina Series B Warrant (right to buy)
Jul 01, 2022 Buy 12 376 Benton Susan Common Stock
Jul 01, 2022 Buy 6 335 Benton Susan Common Stock
Jul 01, 2022 Buy 6 335 Benton Susan Common Stock
Jul 01, 2022 Buy 7 812 Rodgers Richard J Common Stock
Jul 01, 2022 Buy 14 108 Manuso James S J Common Stock
Jul 01, 2022 Buy 9 900 Pepose Jay Common Stock
Jun 13, 2022 Buy 20 000 Rodgers Richard J Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Gallagher Cam Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Gallagher Cam Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Manuso James S J Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Benton Susan Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Benton Susan Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Pepose Jay Stock Option (right to buy)
Jun 13, 2022 Buy 20 000 Ainsworth Sean Stock Option (right to buy)
May 20, 2022 Buy 5 000 Manuso James S J Common Stock
May 19, 2022 Buy 12 500 Sooch Mina Common Stock
Apr 08, 2022 Buy 50 000 Pepose Jay Stock Option (right to buy)
Apr 01, 2022 Buy 3 395 Benton Susan Common Stock
Apr 01, 2022 Buy 3 395 Benton Susan Common Stock
Apr 01, 2022 Buy 4 629 Rodgers Richard J Common Stock
Jan 28, 2022 Buy 42 500 Hoffmann Bernhard Employee Stock Option (right to buy)
Jan 28, 2022 Buy 200 000 Sooch Mina Employee Stock Option (right to buy)
Jan 28, 2022 Buy 50 000 Zaremba Rabourn Amy Employee Stock Option (right to buy)
Jan 03, 2022 Buy 4 021 Rodgers Richard J Common Stock
Dec 31, 2021 Buy 0 Ainsworth Sean
INSIDER POWER
95.878
Last 100 transactions
Buy: 4 068 140 | Sell: 17 369 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 95.878.

In total, the insiders bought 4 068 140 and sold 17 369 OCUP shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Ocuphire Pharma, Inc.

Ocuphire Pharma. Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induc... OCUP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT